Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to st...

Por Hohloch, Karin, Zwick, Carsten, Ziepert, Marita, Hasenclever, Dirk, Kaiser, Ulrich, Engert, Andreas, Höffkes, Heinz-Gert, Kroschinsky, Frank, Mesters, Rolf, Feller, Andreas C, Löffler, Markus, Trümper, Lorenz, Pfreundschuh, Michael
Publicado em 2014

Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study

Por Stein, Alexander, Quidde, Julia, Schröder, Jan Klaus, Göhler, Thomas, Tschechne, Barbara, Valdix, Annette-Rosel, Höffkes, Heinz-Gert, Schirrmacher-Memmel, Silke, Wohlfarth, Tim, Hinke, Axel, Engelen, Andreas, Arnold, Dirk
Publicado no BMC Cancer (2016)

Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial

Por Al-Batran, Salah-Eddin, Homann, Nils, Pauligk, Claudia, Illerhaus, Gerald, Martens, Uwe M., Stoehlmacher, Jan, Schmalenberg, Harald, Luley, Kim B., Prasnikar, Nicole, Egger, Matthias, Probst, Stephan, Messmann, Helmut, Moehler, Markus, Fischbach, Wolfgang, Hartmann, Jörg T., Mayer, Frank, Höffkes, Heinz-Gert, Koenigsmann, Michael, Arnold, Dirk, Kraus, Thomas W., Grimm, Kersten, Berkhoff, Stefan, Post, Stefan, Jäger, Elke, Bechstein, Wolf, Ronellenfitsch, Ulrich, Mönig, Stefan, Hofheinz, Ralf D.
Publicado no JAMA Oncol (2017)